Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Universal Health Services, Inc. Reports 2020 Third Quarter Financial Results

      Consolidated Results of Operations, As Reported and As Adjusted - Three-month periods ended September 30, 2020 and 2019:


      News provided by

      Universal Health Services, Inc.

      Oct 29, 2020, 16:16 ET

      Share this article

      Share this article


      KING OF PRUSSIA, Pa., Oct. 29, 2020 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $241.3 million, or $2.82 per diluted share, during the third quarter of 2020, as compared to $97.2 million, or $1.10 per diluted share, during the comparable quarter of 2019.  Net revenues increased 3.2% to $2.913 billion during the third quarter of 2020 as compared to $2.822 billion during the third quarter of 2019.

      As reflected on the Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule"), our adjusted net income attributable to UHS during the third quarter of 2020 was $246.5 million, or $2.88 per diluted share, as compared to $176.3 million, or $1.99 per diluted share, during the third quarter of 2019. 

      Included in our reported and adjusted net income attributable to UHS during the three-month period ended September 30, 2020 were the following:

      • A favorable impact of approximately $21.4 million, or $0.25 per diluted share, resulting from $28 million of net revenues recorded in connection with the California Medicaid supplemental payment program related to our acute care hospitals. Approximately $11 million of these supplemental revenues were attributable to the first nine months of 2020 and $17 million were attributable to prior years, and;
      • An unfavorable impact of approximately $4.7 million, or $0.06 per diluted share, resulting from a reversal of previously recorded grant income revenues of approximately $5 million, as provided for by the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"), as discussed below in CARES Act and Other Governmental Grants and Medicare Accelerated Payments.

      As reflected on the Supplemental Schedule, included in our reported results during the third quarter of 2020, was a net aggregate unfavorable after-tax impact of $5.2 million, or $.06 per diluted share, consisting of the following: (i) an after-tax unrealized loss of $2.1 million, or $.02 per diluted share, ($2.7 million pre-tax which is included in "Other (income) expense, net"), resulting from a decrease in the market value of shares of certain marketable securities held for investment and classified as available for sale, and; (ii) a unfavorable after-tax impact of $3.1 million, or $.04 per diluted share, resulting from our adoption of ASU 2016-09, "Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting" ("ASU 2016-09").

      As reflected on the Supplemental Schedule, included in our reported results during the third quarter of 2019, is an aggregate net unfavorable after-tax impact of $79.1 million, or $.89 per diluted share, resulting from: (i) an unfavorable after-tax impact of $74.6 million, or $.84 per diluted share, resulting from a $97.6 million provision for asset impairment recorded in connection with Foundations Recovery Network, L.L.C.; (ii) an unfavorable after-tax impact of $6.2 million, or $.07 per diluted share, resulting from the non-deductible portion of the net federal and state income taxes due on the settlement finalized in July, 2020 with the Department of Justice, Civil Division, and; (iii) a favorable after-tax impact of $1.7 million, or $.02 per diluted share, resulting from our adoption of ASU 2016-09.

      Included in our reported and our adjusted net income attributable to UHS during the third quarter of 2019 is a pre-tax unrealized loss of $15.2 million, or $.13 per diluted share (included in "Other (income) expense, net"), resulting from a decrease in the market value of shares of certain marketable securities held for investment and classified as available for sale.  

      As calculated on the attached Supplemental Schedule, our earnings before interest, taxes, depreciation & amortization ("EBITDA net of NCI", NCI is net income attributable to noncontrolling interests), was $471.0 million during the third quarter of 2020, as compared to $297.4 million during the third quarter of 2019. Our adjusted earnings before interest, taxes, depreciation & amortization ("Adjusted EBITDA net of NCI"), which excludes the impact of other (income) expense, net, and the above-mentioned provision for asset impairment recorded during the third quarter of 2019, was $472.8 million during the third quarter of 2020 as compared to $404.4 million during the third quarter of 2019.

      COVID-19

      The impact of the COVID-19 pandemic, which began during the second half of March, 2020, has had a material unfavorable effect on our operations and financial results since that time, before giving effect to the revenues recorded in connection with the CARES Act and other governmental grants as discussed below in CARES Act and Other Governmental Grants and Medicare Accelerated Payments. Patient volumes at both our acute care and behavioral health care facilities were most significantly reduced in March and April. Our acute care and behavioral health facilities began experiencing gradual and continued improvement in patient volumes since May as various states eased stay-at-home restrictions and acute care hospitals were permitted to resume elective surgeries and procedures.  Although many of our acute care and behavioral health facilities are located in states that have continued to experience intermittent increases in COVID-19 infections, non-COVID-19 patient volumes at our hospitals have not been as dramatically impacted in recent months by increases experienced from time-to-time in COVID-19 patient volumes. We believe that the adverse impact that COVID-19 will have on our future operations and financial results will depend upon many factors, most of which are beyond our capability to control or predict. 

      Consolidated Results of Operations, As Reported and As Adjusted  – Nine-month periods ended September 30, 2020 and 2019:

      Reported net income attributable to UHS was $635.2 million, or $7.40 per diluted share, during the nine-month period ended September 30, 2020, as compared to $569.7 million, or $6.35 per diluted share, during the first nine months of 2019.  Net revenues decreased slightly to $8.472 billion during the first nine months of 2020 as compared to $8.482 billion during the comparable period of 2019.

      As reflected on the Supplemental Schedule, our adjusted net income attributable to UHS during the nine-month period ended September 30, 2020 was $646.9 million, or $7.53 per diluted share, as compared to $646.7 million, or $7.21 per diluted share, during the first nine months of 2019. 

      Our reported and adjusted net income attributable to UHS during the nine-month period ended September 30, 2020 included the following:

      • A favorable impact of $157.2 million, or $1.84 per diluted share, resulting from the recording of approximately $213 million of grant income revenues, as discussed below in CARES Act and Other Governmental Grants and Medicare Accelerated Payments, and;
      • A favorable impact of $21.4 million, or $0.25 per diluted share, resulting from the above-mentioned $28 million of net revenues recorded during the third quarter of 2020 in connection with the California Medicaid supplemental payment program.

      As reflected on the Supplemental Schedule, included in our reported results during the nine-month period ended September 30, 2020, was a net aggregate unfavorable after-tax impact of $11.6 million, or $.13 per diluted share, consisting of the following: (i) an after-tax unrealized loss of $7.2 million, or $.08 per diluted share, ($9.4 million pre-tax which is included in "Other (income) expense, net"), resulting from a decrease in the market value of shares of certain marketable securities held for investment and classified as available for sale, and; (ii) an unfavorable after-tax impact of $4.4 million, or $.05 per diluted share, resulting from our adoption of ASU 2016-09.

      As reflected on the Supplemental Schedule, included in our reported results during the nine-month period ended September 30, 2019, is an aggregate net unfavorable after-tax impact of $77.0 million, or $.86 per diluted share, resulting from: (i) an unfavorable after-tax impact of $74.6 million, or $.84 per diluted share, resulting from a $97.6 million provision for asset impairment recorded in connection with Foundations Recovery Network, L.L.C.; (ii) an unfavorable after-tax impact of $14.6 million, or $.16 per diluted share, resulting from the non-deductible portion of the net federal and state income taxes due on the settlement finalized in July, 2020 with the Department of Justice, Civil Division, and; (iii) a favorable after-tax impact of $12.1 million, or $.14 per diluted share, resulting from our adoption of ASU 2016-09.

      Included in our reported and our adjusted net income attributable to UHS during the nine-month period ended September 30, 2019 is a pre-tax unrealized loss of $12.5 million, or $.11 per diluted share (included in "Other (income) expense, net"), resulting from a decrease in the market value of shares of certain marketable securities held for investment and classified as available for sale.  

      As calculated on the attached Supplemental Schedule, our EBITDA net of NCI was $1.303 billion during the first nine months of 2020, as compared to $1.222 billion during the first nine months of 2019. Our Adjusted EBITDA net of NCI, which excludes the impact of other (income) expense, net, and the increase in the Department of Justice settlement reserve and the provision for asset impairment, both of which were recorded during the first nine months of 2019, was $1.311 billion during the nine-month period ended September 30, 2020 and $1.336 billion during the comparable period of 2019.

      Acute Care Services – Three and nine-month periods ended September 30, 2020 and 2019:

      During the third quarter of 2020, at our acute care hospitals owned during both periods ("same facility basis"), adjusted admissions (adjusted for outpatient activity) decreased 17.3% and adjusted patient days decreased 1.6%, as compared to the third quarter of 2019. At these facilities, excluding the CARES Act and other grant income revenues of approximately $4 million recorded during the third quarter of 2020, net revenue per adjusted admission increased 26.2% while net revenue per adjusted patient day increased 6.0% during the third quarter of 2020 as compared to the third quarter of 2019. During the third quarter of 2020, as compared to the third quarter of 2019, net revenues generated from our acute care services on a same facility basis increased 5.5% including the impact of the CARES Act and other grant income revenues, and increased 5.2% excluding the impact of the CARES Act and other grant income revenues.

      During the nine-month period ended September 30, 2020, at our acute care hospitals on a same facility basis, adjusted admissions decreased 15.4% and adjusted patient days decreased 6.6%, as compared to the first nine months of 2019. At these facilities, excluding the CARES Act and other grant income revenues of approximately $161 million recorded during the first nine months of 2020, net revenue per adjusted admission increased 13.8% while net revenue per adjusted patient day increased 3.0% during the nine-month period ended September 30, 2020 as compared to the comparable nine-month period of 2019. During the first nine months of 2020, as compared to the comparable period of 2019, net revenues generated from our acute care services on a same facility basis increased 0.8% including the CARES Act and other grant income revenues, and decreased 2.8% excluding the CARES Act and other grant income revenues.

      Behavioral Health Care Services – Three and nine-month periods ended September 30, 2020 and 2019:

      During the third quarter of 2020, at our behavioral health care facilities on a same facility basis, adjusted admissions decreased 5.6% while adjusted patient days decreased 3.6% as compared to the third quarter of 2019. At these facilities, excluding the impact of the CARES Act and other grant income revenue reversal of approximately $9 million recorded during the third quarter of 2020, net revenue per adjusted admission increased 8.0% while net revenue per adjusted patient day increased 5.7% during the third quarter of 2020 as compared to the comparable quarter in 2019. During the third quarter of 2020, as compared to the third quarter of 2019, net revenues generated from our behavioral health care services on a same facility basis increased 1.2% including the impact of the CARES Act and other grant income revenue reversal, and increased 1.9% excluding the impact of the CARES Act and other grant income revenue reversal.     

      During the nine-month period ended September 30, 2020, at our behavioral health care facilities on a same facility basis, adjusted admissions decreased 7.6% and adjusted patient days decreased 5.1%, as compared to the first nine months of 2019. At these facilities, excluding the CARES Act and other grant income revenues of approximately $52 million recorded during the first nine months of 2020, net revenue per adjusted admission increased 6.6% while net revenue per adjusted patient day increased 3.8% during the first nine months of 2020 as compared to the comparable period of 2019. During the first nine months of 2020, as compared to the comparable period of 2019, net revenues generated from our behavioral health care services on a same facility basis decreased 0.2% including the CARES Act and other grant income revenues, and decreased 1.5% excluding the CARES Act and other grant income revenues.

      Net Cash Provided by Operating Activities and Liquidity:

      Net Cash Provided by Operating Activities:

      For the nine months ended September 30, 2020, our net cash provided by operating activities increased to $2.218 billion as compared to $1.105 billion generated during the first nine months of 2019.

      The $1.113 billion net increase was due to: (i) a favorable change of $878 million resulting from the Medicare accelerated payments and deferred CARES Act and other grants; (ii) a favorable change of $111 million due to the payment deferral of the employer's share of Social Security taxes, as provided for by the CARES Act; (iii) a favorable change of $52 million in accrued and deferred income taxes; (iv) a favorable change of $49 million in accounts receivable; (v) a favorable change $30 million in other working capital accounts due primarily to the timing of accounts payable disbursements, and; (vi) $7 million of other combined net unfavorable changes.   

      Liquidity:

      As of September 30, 2020, there were no borrowings outstanding pursuant to our $1 billion revolving credit facility or our $450 million accounts receivable securitization program.  As of that date, we had $1.447 billion of aggregate available borrowing capacity pursuant to the terms of these debt facilities, net of outstanding letters of credit.    

      In addition, as of September 30, 2020, we had approximately $1.101 billion of cash and cash equivalents.  

      CARES Act and Other Governmental Grants and Medicare Accelerated Payments:

      As of September 30, 2020, we have received an aggregate of $1.091 billion as follows:

      • Approximately $396 million of funds received from various governmental stimulus programs, most notably the Public Health and Social Services Emergency Fund, as provided for by the CARES Act.
        • Included in our reported and adjusted net income attributable to UHS for the three-month period ended September 30, 2020, was an unfavorable impact of $4.7 million, or $0.06 per diluted share, resulting from a reversal of previously recorded CARES Act and other grant income revenues of approximately $5 million. During the third quarter of 2020, approximately $4 million of grant income revenues were recorded by our acute care services, while our behavioral health services reversed approximately $9 million of previously recorded CARES Act and other grant income revenues.
        • Included in our reported and adjusted net income attributable to UHS for the nine-month period ended September 30, 2020, was the favorable impact of $157.2 million, or $1.84 per diluted share, resulting from the recording of approximately $213 million of CARES Act and other grant income revenues. Approximately $161 million of the grant income revenues were attributable to our acute care services and approximately $52 million were attributable to our behavioral health care services.
        • As of September 30, 2020, approximately $183 million of these funds remain in the Medicare accelerated payments and deferred CARES Act and other grants liability account in our condensed consolidated balance sheet.
      • Approximately $695 million of Medicare accelerated payments received. Pursuant to legislation enacted on October 1, 2020, these funds are required to be repaid to the government beginning in the second quarter of 2021 through the third quarter of 2022 through withholding of future Medicare revenues earned during those periods. There was no impact on our earnings during the three and nine-month periods ended September 30, 2020 in connection with receipt of these funds. As of September 30, 2020, the funds are included in the Medicare accelerated payments and deferred CARES Act and other grants liability account in our condensed balance sheet.

      We recognized grant income net revenues related to the CARES Act and other governmental grant funding based on information available at September 30, 2020 based upon laws and regulations governing the funding as well as interpretations issued by the Department of Health and Human Services ("HHS").  In October 2020, HHS issued new reporting requirements for the CARES Act funding. Due to these new reporting requirements and various interpretations, there is at least a reasonable possibility that amounts recorded under CARES Act funding will change in future periods. 

      Update on Previously Disclosed Information Technology Incident:

      As previously disclosed on September 29, 2020, we experienced an information technology security incident in the early morning hours of September 27, 2020. As a result of this cyberattack, we suspended user access to our information technology applications related to operations located in the United States. While our information technology applications were offline, patient care was delivered safely and effectively at our facilities across the country utilizing established back-up processes, including offline documentation methods.

      Since that time, our information technology applications have been restored at our acute care and behavioral health hospitals, as well as at the corporate level, thereby re-establishing connections to all major systems and applications, including electronic medical records, laboratory and pharmacy systems. With the back-loading of data substantially complete at this point, our hospitals are resuming normal operations.

      We have worked diligently with our information technology security partners to restore our information technology infrastructure and business operations as quickly as possible.  In parallel, we immediately began investigating the nature and potential impact of the security incident and engaged third-party information technology and forensic vendors to assist. Although the investigation remains ongoing, no evidence of unauthorized access, copying or misuse of any patient or employee data has been identified to date.  

      Conference call information:

      We will hold a conference call for investors and analysts at 10:00 a.m. eastern time on October 30, 2020. The dial-in number is 1-877-648-7971. 

      A live broadcast of the conference call will be available on our website at www.uhsinc.com. Also, a replay of the call will be available following the conclusion of the live call and will be available for one full year.

      General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures:

      One of the nation's largest and most respected providers of hospital and healthcare services, Universal Health Services, Inc. has built an impressive record of achievement and performance. Growing steadily since our inception into an esteemed Fortune 500 corporation, our annual revenues were approximately $11.4 billion during 2019. In 2020, UHS was again recognized as one of the World's Most Admired Companies by Fortune; ranked #281 on the Fortune 500; and listed #330 in Forbes ranking of U.S.' Largest Public Companies.

      Our operating philosophy is as effective today as it was 40 years ago, enabling us to provide compassionate care to our patients and their loved ones.  Our strategy includes building or acquiring high quality hospitals in rapidly growing markets, investing in the people and equipment needed to allow each facility to thrive, and becoming the leading healthcare provider in each community we serve.

      Headquartered in King of Prussia, PA, UHS has more than 90,000 employees and through its subsidiaries operates 26 acute care hospitals, 330 behavioral health facilities, 41 outpatient facilities and ambulatory care access points, an insurance offering, a physician network and various related services located in 37 U.S. states, Washington, D.C., Puerto Rico and the United Kingdom. It acts as the advisor to Universal Health Realty Income Trust, a real estate investment trust (NYSE:UHT).  For additional information on the Company, visit our web site: http://www.uhsinc.com.

      This press release contains forward-looking statements based on current management expectations.  Numerous factors, including those disclosed herein, those related to the anticipated impact of COVID-19 on our operations and financial results, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission (as set forth in Item 1A-Risk Factors and in Item 7-Forward-Looking Statements and Risk Factors in our Form 10-Q for the quarterly period ended June 30, 2020), may cause the results to differ materially from those anticipated in the forward-looking statements.  These statements are subject to risks and uncertainties and therefore actual results may differ materially.  Readers should not place undue reliance on such forward-looking statements which reflect management's view only as of the date hereof.  We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.  Many of the factors that could affect our future results are beyond our control or ability to predict, including the impact of the COVID-19 pandemic. Our future operations and financial results will likely be materially impacted by developments related to COVID-19 including, but not limited to, the length of time and severity of the spread of the pandemic; the volume of cancelled or rescheduled elective procedures and the volume of COVID-19 patients treated at our hospitals and other healthcare facilities; measures we are taking to respond to the COVID-19 pandemic; the impact of government and administrative regulation and stimulus on the hospital industry and potential retrospective adjustment in future periods of CARES Act and other grant income revenues recorded as revenues in prior periods; declining patient volumes and unfavorable changes in payer mix caused by deteriorating macroeconomic conditions (including increases in uninsured and underinsured patients as the result of business closings and layoffs); potential disruptions to our clinical staffing and shortages and disruptions related to supplies required for our employees and patients; and potential increases to expenses related to staffing, supply chain or other expenditures; the impact of our substantial indebtedness and the ability to refinance such indebtedness on acceptable terms, as well as risks associated with disruptions in the financial markets and the business of financial institutions as the result of the COVID-19 pandemic which could impact us from a financing perspective; and changes in general economic conditions nationally and regionally in our markets resulting from the COVID-19 pandemic. We are not able to fully quantify the impact that these factors will have on our future financial results, but expect developments related to the COVID-19 pandemic to materially affect our financial performance in 2020.  In addition, although we are unable to quantify the ultimate impact of the above-mentioned information technology security incident that we experienced in late September, 2020, the incident could have an adverse effect on our future results of operations.

      We believe that adjusted net income attributable to UHS, adjusted net income attributable to UHS per diluted share, EBITDA net of NCI and Adjusted EBITDA net of NCI, which are non-GAAP financial measures ("GAAP" is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to our investors since it neutralizes the effect of material items impacting our net income attributable to UHS, such as, our adoption of ASU 2016-09, unrealized gains/losses resulting from changes in the market value of shares of certain marketable securities held for investment and classified as available for sale, and other potential material items that are nonrecurring or non-operational in nature including, but not limited to, impairments of long-lived and intangible assets, changes in the reserve established in connection with our discussions with the Department of Justice, reserves for various matters including settlements, legal judgments and lawsuits, costs related to extinguishment of debt, gains/losses on sales of assets and businesses, and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. To obtain a complete understanding of our financial performance these measures should be examined in connection with net income attributable to UHS, as determined in accordance with GAAP, and as presented in the condensed consolidated financial statements and notes thereto in this report or in our other filings with the Securities and Exchange Commission including our Reports on Form 10-K for the year ended December 31, 2019 and Form 10-Q for the quarterly period ended June 30, 2020. Since the items included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP, these measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented, are not determined in accordance with GAAP and are thus susceptible to varying calculations, they may not be comparable to other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.

      Universal Health Services, Inc.

      Consolidated Statements of Income

      (in thousands, except per share amounts)

      (unaudited)










      Three months


      Nine months


      ended September 30,


      ended September 30,


      2020


      2019


      2020


      2019









      Net revenues

      $2,912,541


      $2,822,453


      $8,471,962


      $8,482,012









      Operating charges:








         Salaries, wages and benefits

      1,406,348


      1,408,226


      4,147,027


      4,157,253

         Other operating expenses

      666,665


      762,174


      1,982,202


      2,079,518

         Supplies expense

      335,409


      313,936


      936,808


      927,256

         Depreciation and amortization

      125,961


      121,528


      376,563


      362,736

         Lease and rental expense

      28,488


      27,660


      84,967


      80,320


      2,562,871


      2,633,524


      7,527,567


      7,607,083









      Income from operations

      349,670


      188,929


      944,395


      874,929









      Interest expense, net

      24,575


      41,447


      86,399


      123,574

      Other (income) expense, net

      1,831


      9,407


      8,291


      6,176









      Income before income taxes

      323,264


      138,075


      849,705


      745,179









      Provision for income taxes

      79,172


      37,205


      204,649


      165,646









      Net income

      244,092


      100,870


      645,056


      579,533









      Less:  Net income attributable to








      noncontrolling interests ("NCI")

      2,813


      3,680


      9,811


      9,855









      Net income attributable to UHS

      $241,279


      $97,190


      $635,245


      $569,678

















































      Basic earnings per share attributable to UHS (a)

      $2.84


      $1.10


      $7.44


      $6.36









      Diluted earnings per share attributable to UHS (a)

      $2.82


      $1.10


      $7.40


      $6.35

      Universal Health Services, Inc.

      Footnotes to Consolidated Statements of Income

      (in thousands, except per share amounts)

      (unaudited)










      Three months


      Nine months

      (a) Earnings per share calculation:

      ended September 30,


      ended September 30,


      2020


      2019


      2020


      2019

      Basic and diluted:








      Net income attributable to UHS

      $241,279


      $97,190


      $635,245


      $569,678

      Less: Net income attributable to unvested restricted share grants

      (790)


      (243)


      (1,987)


      (1,414)

      Net income attributable to UHS - basic and diluted

      $240,489


      $96,947


      $633,258


      $568,264









      Weighted average number of common shares - basic

      84,672


      87,952


      85,172


      89,288









      Basic earnings per share attributable to UHS:

      $2.84


      $1.10


      $7.44


      $6.36









      Weighted average number of common shares

      84,672


      87,952


      85,172


      89,288

      Add: Other share equivalents

      575


      403


      415


      231

      Weighted average number of common shares and equiv. - diluted

      85,247


      88,355


      85,587


      89,519









      Diluted earnings per share attributable to UHS:

      $2.82


      $1.10


      $7.40


      $6.35

      Universal Health Services, Inc.

      Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule")

      For the Three Months ended September 30, 2020 and 2019

      (in thousands, except per share amounts)

      (unaudited)

























      Calculation of Earnings/Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA/Adjusted EBITDA net of NCI")










      Three months ended


      % Net


      Three months ended


      % Net


      September 30, 2020


      revenues


      September 30, 2019


      revenues









      Net income attributable to UHS

      $241,279




      $97,190



         Depreciation and amortization

      125,961




      121,528



         Interest expense, net

      24,575




      41,447



         Provision for income taxes

      79,172




      37,205



      EBITDA net of NCI

      $470,987


      16.2%


      $297,370


      10.5%









      Other (income) expense, net

      1,831




      9,407



      Provision for asset impairment

      -




      97,631



      Adjusted EBITDA net of NCI

      $472,818


      16.2%


      $404,408


      14.3%









      Net revenues

      $2,912,541




      $2,822,453











































      Calculation of Adjusted Net Income Attributable to UHS










      Three months ended


      Three months ended


      September 30, 2020


      September 30, 2019




      Per




      Per


      Amount


      Diluted Share


      Amount


      Diluted Share









      Net income attributable to UHS

      $241,279


      $2.82


      $97,190


      $1.10

      Plus/minus after-tax adjustments:








      Unrealized loss on marketable securities held for sale

      2,066


      0.02


      -


      -

      Increase in DOJ Reserve and related income taxes

      -


      -


      6,214


      0.07

      Impact of ASU 2016-09

      3,137


      0.04


      (1,724)


      (0.02)

      Provision for asset impairment

      -


      -


      74,583


      0.84

      Subtotal adjustments

      5,203


      0.06


      79,073


      0.89

      Adjusted net income attributable to UHS

      $246,482


      $2.88


      $176,263


      $1.99

      Universal Health Services, Inc.

      Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule")

      For the Nine Months ended September 30, 2020 and 2019

      (in thousands, except per share amounts)

      (unaudited)

























      Calculation of Earnings/Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA/Adjusted EBITDA net of NCI")










      Nine months ended


      % Net


      Nine months ended


      % Net


      September 30, 2020


      revenues


      September 30, 2019


      revenues









      Net income attributable to UHS

      $635,245




      $569,678



         Depreciation and amortization

      376,563




      362,736



         Interest expense, net

      86,399




      123,574



         Provision for income taxes

      204,649




      165,646



      EBITDA net of NCI

      $1,302,856


      15.4%


      $1,221,634


      14.4%









      Other (income) expense, net

      8,291




      6,176



      Increase in DOJ Reserve

      -




      10,978



      Provision for asset impairment

      -




      97,631



      Adjusted EBITDA net of NCI

      $1,311,147


      15.5%


      $1,336,419


      15.8%









      Net revenues

      $8,471,962




      $8,482,012











































      Calculation of Adjusted Net Income Attributable to UHS










      Nine months ended


      Nine months ended


      September 30, 2020


      September 30, 2019




      Per




      Per


      Amount


      Diluted Share


      Amount


      Diluted Share









      Net income attributable to UHS

      $635,245


      $7.40


      $569,678


      $6.35

      Plus/minus after-tax adjustments:








      Unrealized loss on marketable securities held for sale

      7,193


      0.08


      -


      -

      Increase in DOJ Reserve and related income taxes

      -


      -


      14,583


      0.16

      Impact of ASU 2016-09

      4,412


      0.05


      (12,122)


      (0.14)

      Provision for asset impairment

      -


      -


      74,583


      0.84

      Subtotal adjustments

      11,605


      0.13


      77,044


      0.86

      Adjusted net income attributable to UHS

      $646,850


      $7.53


      $646,722


      $7.21

      Universal Health Services, Inc.

      Consolidated Statements of Comprehensive Income

      (in thousands)

      (unaudited)










      Three months


      Nine months


      ended September 30,


      ended September 30,


      2020


      2019


      2020


      2019









      Net income

      $244,092


      $100,870


      $645,056


      $579,533

      Other comprehensive income (loss):








         Unrealized derivative gains (losses) on cash flow hedges

      0


      0


      0


      (3,925)

         Foreign currency translation adjustment

      14,245


      (10,089)


      (18,280)


      (19,192)

      Other comprehensive income (loss) before tax

      14,245


      (10,089)


      (18,280)


      (23,117)

      Income tax expense (benefit) related to items of other comprehensive income (loss)

      302


      174


      (908)


      (676)

      Total other comprehensive income (loss), net of tax

      13,943


      (10,263)


      (17,372)


      (22,441)









      Comprehensive income

      258,035


      90,607


      627,684


      557,092

      Less: Comprehensive income attributable to noncontrolling interests

      2,813


      3,680


      9,811


      9,855

      Comprehensive income attributable to UHS

      $255,222


      $86,927


      $617,873


      $547,237

      Universal Health Services, Inc.

      Condensed Consolidated Balance Sheets

      (in thousands)

      (unaudited)












      September 30,



      December 31,





      2020



      2019


      Assets








      Current assets:








          Cash and cash equivalents


      $

      1,101,230


      $

      61,268


          Accounts receivable, net



      1,574,751



      1,560,847


          Supplies



      176,105



      159,889


          Other current assets



      143,072



      133,930


                Total current assets



      2,995,158



      1,915,934










      Property and equipment



      9,652,778



      9,106,377


      Less: accumulated depreciation



      (4,403,941)



      (4,089,679)





      5,248,837



      5,016,698










      Other assets:








          Goodwill



      3,854,265



      3,869,760


          Deferred income taxes



      19,936



      16,189


          Right of use assets-operating leases



      330,172



      326,518


          Deferred charges



      5,136



      6,373


          Other



      556,258



      516,778


      Total Assets


      $

      13,009,762


      $

      11,668,250










      Liabilities and Stockholders' Equity








      Current liabilities:








          Current maturities of long-term debt


      $

      94,504


      $

      87,550


          Accounts payable and other liabilities



      1,625,262



      1,272,374


          Medicare accelerated payments and deferred CARES Act and other grants


      878,480



      0


          Legal reserves



      5,426



      144,509


          Operating lease liabilities



      57,219



      56,442


          Federal and state taxes



      7,335



      2,515


                Total current liabilities



      2,668,226



      1,563,390










      Other noncurrent liabilities



      488,457



      329,932


      Operating lease liabilities noncurrent



      274,236



      270,076


      Long-term debt



      3,514,673



      3,896,577


      Deferred income taxes



      24,895



      25,071










      Redeemable noncontrolling interest



      4,177



      4,333










      UHS common stockholders' equity



      5,962,788



      5,504,105


      Noncontrolling interest



      72,310



      74,766


                Total equity



      6,035,098



      5,578,871










      Total Liabilities and Stockholders' Equity


      $

      13,009,762


      $

      11,668,250


      Universal Health Services, Inc.

      Consolidated Statements of Cash Flows

      (in thousands)

      (unaudited)


      Nine months




      ended September 30,


      2020


      2019





      Cash Flows from Operating Activities:




        Net income

      $645,056


      $579,533

        Adjustments to reconcile net income to net 




      cash provided by operating activities:




      Depreciation & amortization

      376,563


      362,736

      (Gain) loss on sale of assets and businesses

      2,124


      (5,982)

      Stock-based compensation expense

      49,928


      52,167

      Costs related to extinguishment of debt

      1,365


      0

      Provision for asset impairment

      0


      97,631

        Changes in assets & liabilities, net of effects from




      acquisitions and dispositions:




         Accounts receivable

      11,431


      (37,332)

         Accrued interest

      (10,526)


      (2,962)

         Accrued and deferred income taxes 

      (2,095)


      (53,714)

         Other working capital accounts 

      119,948


      90,262

         Medicare accelerated payments and deferred CARES Act and other grants

      878,480


      0

         Other assets and deferred charges

      1,271


      15,237

         Other 

      115,431


      (663)

         Accrued insurance expense, net of commercial premiums paid

      113,571


      76,245

         Payments made in settlement of self-insurance claims

      (84,390)


      (68,046)

                Net cash provided by operating activities

      2,218,157


      1,105,112





      Cash Flows from Investing Activities:




         Property and equipment additions, net of disposals

      (546,656)


      (480,247)

         Proceeds received from sales of assets and businesses

      7,851


      7,497

         Acquisition of businesses and property

      (52,009)


      0

         Inflows from foreign exchange contracts that hedge our net U.K. investment

      22,453


      34,484

         Costs incurred for purchase and implementation of information technology applications

      (5,345)


      (18,240)

         Investment in, and advances to,  joint ventures and other

      (997)


      (11,949)

                Net cash used in investing activities

      (574,703)


      (468,455)





      Cash Flows from Financing Activities:




         Reduction of long-term debt

      (1,173,590)


      (68,175)

         Additional borrowings

      803,197


      15,100

         Financing costs

      (8,256)


      0

         Repurchase of common shares

      (200,098)


      (587,976)

         Dividends paid

      (17,344)


      (35,556)

         Issuance of common stock

      9,288


      8,248

         Profit distributions to noncontrolling interests

      (15,175)


      (11,887)

         Purchase of ownership interests from minority members

      (548)


      0

                Net cash used in financing activities

      (602,526)


      (680,246)





         Effect of exchange rate changes on cash, cash equivalents and restricted cash

      (706)


      (1,259)

      Increase (decrease) in cash, cash equivalents and restricted cash

      1,040,222


      (44,848)

      Cash, cash equivalents and restricted cash, beginning of period

      105,667


      199,685

      Cash, cash equivalents and restricted cash, end of period

      $1,145,889


      $154,837





      Supplemental Disclosures of Cash Flow Information:




        Interest paid

      $93,579


      $122,699





        Income taxes paid, net of refunds

      $208,460


      $221,298





        Noncash purchases of property and equipment

      $76,402


      $83,552





        Right-of-use assets obtained in exchange for lease obligations

      $47,679


      $364,453

      Universal Health Services, Inc.



      Supplemental Statistical Information



      (unaudited)























       % Change 


       % Change 








      Quarter ended


      9 months ended

      Same Facility:







      9/30/2020


      9/30/2020











      Acute Care Hospitals










      Revenues (a)







      5.5%


      0.8%

      Revenues-excludes CARES Act and other grant income




      5.2%


      -2.8%

      Adjusted Admissions







      -17.3%


      -15.4%

      Adjusted Patient Days







      -1.6%


      -6.6%

      Revenue Per Adjusted Admission-excludes CARES Act and other grant income


      26.2%


      13.8%

      Revenue Per Adjusted Patient Day-excludes CARES Act and other grant income

      6.0%


      3.0%











      Behavioral Health Hospitals










      Revenues (b)







      1.2%


      -0.2%

      Revenues-excludes CARES Act and other grant income




      1.9%


      -1.5%

      Adjusted Admissions







      -5.6%


      -7.6%

      Adjusted Patient Days







      -3.6%


      -5.1%

      Revenue Per Adjusted Admission-excludes CARES Act and other grant income


      8.0%


      6.6%

      Revenue Per Adjusted Patient Day-excludes CARES Act and other grant income

      5.7%


      3.8%











      (a) Includes CARES Act and other grant income of $4 million and $161 million recorded in the three and nine-months periods ended September 30, 2020, respectively.

      (b) Includes the reversal of CARES Act and other grant income of $9 million and CARES Act and other grant income of $52 million recorded in the three and nine-months periods ended September 30, 2020, respectively.





















      UHS Consolidated



      third quarter ended


      nine months ended




      9/30/2020


      9/30/2019


      9/30/2020


      9/30/2019











      Revenues



      $2,912,541


      $2,822,453


      $8,471,962


      $8,482,012

      EBITDA net of NCI



      $470,987


      $297,370


      $1,302,856


      $1,221,634

      EBITDA Margin net of NCI



      16.2%


      10.5%


      15.4%


      14.4%

      Adjusted EBITDA net of NCI



      $472,818


      $404,408


      $1,311,147


      $1,336,419

      Adjusted EBITDA Margin net of NCI


      16.2%


      14.3%


      15.5%


      15.8%











      Cash Flow From Operations







      $2,218,157


      $1,105,112

      Days Sales Outstanding







      51


      50

      Capital Expenditures  







      $546,656


      $480,247











      Debt 







      $3,609,177


      $3,948,371

      UHS' Shareholders Equity







      $5,962,788


      $5,389,215

      Debt / Total Capitalization







      37.7%


      42.3%

      Debt / EBITDA net of NCI (1)







      2.02


      2.50

      Debt / Adjusted EBITDA net of NCI (1)





      2.03


      2.21

      Debt / Cash From Operations (1)







      1.41


      2.76

      Net Debt / EBITDA net of NCI (1) (2)






      1.40



      Net Debt / Adjusted EBITDA net of NCI (1) (2)




      1.41



      Net Debt / Cash From Operations (1) (2)





      0.98













      (1) Latest 4 quarters

      (2) Debt, net of $1.101 billion of cash and cash equivalents as of September 30, 2020

      Universal Health Services, Inc.

      Acute Care Hospital Services

      For the Three and Nine Months ended

      September 30, 2020 and 2019

      (in thousands)



































      Same Facility Basis - Acute Care Hospital Services




































      Three months ended


      Three months ended


      Nine months ended


      Nine months ended



      September 30, 2020


      September 30, 2019


      September 30, 2020


      September 30, 2019



      Amount


      % of Net
      Revenues 


      Amount


      % of Net
      Revenues 


      Amount


      % of Net
      Revenues 


      Amount


      % of Net
      Revenues 

      Net revenues (a)


      $1,585,142


      100.0%


      $1,502,891


      100.0%


      $4,528,364


      100.0%


      $4,493,296


      100.0%

      Operating charges:

















      Salaries, wages and benefits


      660,610


      41.7%


      653,792


      43.5%


      1,909,216


      42.2%


      1,897,144


      42.2%

      Other operating expenses


      366,754


      23.1%


      344,681


      22.9%


      1,086,669


      24.0%


      1,017,833


      22.7%

      Supplies expense


      283,829


      17.9%


      263,462


      17.5%


      781,778


      17.3%


      777,309


      17.3%

      Depreciation and amortization


      78,388


      4.9%


      76,318


      5.1%


      234,756


      5.2%


      226,489


      5.0%

      Lease and rental expense


      17,641


      1.1%


      16,235


      1.1%


      50,224


      1.1%


      45,270


      1.0%

      Subtotal-operating expenses


      1,407,222


      88.8%


      1,354,488


      90.1%


      4,062,643


      89.7%


      3,964,045


      88.2%

      Income from operations


      177,920


      11.2%


      148,403


      9.9%


      465,721


      10.3%


      529,251


      11.8%

      Interest expense, net


      205


      0.0%


      305


      0.0%


      1,339


      0.0%


      828


      0.0%

      Other (income) expense, net


      -


      -


      13


      0.0%


      -


      -


      (32)


      (0.0)%

      Income before income taxes


      $177,715


      11.2%


      $148,085


      9.9%


      $464,382


      10.3%


      $528,455


      11.8%




















































      All Acute Care Hospital Services




































      Three months ended


      Three months ended


      Nine months ended


      Nine months ended



      September 30, 2020


      September 30, 2019


      September 30, 2020


      September 30, 2019



      Amount


      % of Net
      Revenues


      Amount


      % of Net
      Revenues 


      Amount


      % of Net
      Revenues


      Amount


      % of Net
      Revenues 

      Net revenues (a)


      $1,610,003


      100.0%


      $1,528,535


      100.0%


      $4,598,558


      100.0%


      $4,575,088


      100.0%

      Operating charges:

















      Salaries, wages and benefits


      660,694


      41.0%


      653,792


      42.8%


      1,909,415


      41.5%


      1,897,144


      41.5%

      Other operating expenses


      391,642


      24.3%


      370,325


      24.2%


      1,156,909


      25.2%


      1,099,625


      24.0%

      Supplies expense


      283,827


      17.6%


      263,462


      17.2%


      781,776


      17.0%


      777,309


      17.0%

      Depreciation and amortization


      78,388


      4.9%


      76,318


      5.0%


      234,756


      5.1%


      226,489


      5.0%

      Lease and rental expense


      17,641


      1.1%


      16,235


      1.1%


      50,224


      1.1%


      45,270


      1.0%

      Subtotal-operating expenses


      1,432,192


      89.0%


      1,380,132


      90.3%


      4,133,080


      89.9%


      4,045,837


      88.4%

      Income from operations


      177,811


      11.0%


      148,403


      9.7%


      465,478


      10.1%


      529,251


      11.6%

      Interest expense, net


      205


      0.0%


      305


      0.0%


      1,339


      0.0%


      828


      0.0%

      Other (income) expense, net


      -


      -


      13


      0.0%


      -


      -


      (32)


      (0.0)%

      Income before income taxes


      $177,606


      11.0%


      $148,085


      9.7%


      $464,139


      10.1%


      $528,455


      11.6%


















      (a) Includes CARES Act and other grant income of $4 million and $161 million recorded in the three and nine-months periods ended September 30, 2020, respectively.

      We believe that providing our results on a "Same Facility" basis (which is a non-GAAP measure), which includes the operating results for facilities and businesses operated in both the current year and prior year periods, is helpful to our investors as a measure of our operating performance. Our Same Facility results also neutralize (if applicable), the effect of material items that are nonrecurring or non-operational in nature including items such as, but not limited to, reserves for various matters, settlements, legal judgments and lawsuits, cost related to extinguishment of debt, gains/losses on sales of assets and businesses, impairments of long-lived and intangible assets and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. Our Same Facility basis results exclude from net revenues and other operating expenses, provider tax assessments incurred in each period. However, these provider tax assessments are included in net revenues and other operating expenses as reflected in the table under All Acute Care Hospital Services. The provider tax assessments had no impact on the income before income taxes as reflected on the above tables since the amounts offset between net revenues and other operating expenses. To obtain a complete understanding of our financial performance, the Same Facility results should be examined in connection with our net income as determined in accordance with GAAP and as presented herein and the condensed consolidated financial statements and notes thereto as contained in our Form 10-K for the year ended December 31, 2019 and Form 10-Q for the quarter ended June 30, 2020.


















      The All Acute Care Hospital Services table summarizes the results of operations for all our acute care operations during the periods presented. These amounts include: (i) our acute care results on a same facility basis, as indicated above; (ii) the impact of provider tax assessments which increased net revenues and other operating expenses but had no impact on income before income taxes, and; (iii) certain other amounts including the results of facilities acquired or opened during the last twelve months.

      Universal Health Services, Inc.

      Behavioral Health Care Services

      For the Three and Nine Months ended

      September 30, 2020 and 2019

      (in thousands)



































      Same Facility - Behavioral Health Care Services




































      Three months ended


      Three months ended


      Nine months ended


      Nine months ended



      September 30, 2020


      September 30, 2019


      September 30, 2020


      September 30, 2019



      Amount


      % of Net
      Revenues 


      Amount


      % of Net
      Revenues 


      Amount


      % of Net
      Revenues 


      Amount


      % of Net
      Revenues 

      Net revenues (a)


      $1,276,975


      100.0%


      $1,261,774


      100.0%


      $3,801,606


      100.0%


      $3,807,798


      100.0%

      Operating charges:

















      Salaries, wages and benefits


      683,441


      53.5%


      683,345


      54.2%


      2,024,303


      53.2%


      2,027,271


      53.2%

      Other operating expenses


      230,060


      18.0%


      239,548


      19.0%


      694,978


      18.3%


      714,310


      18.8%

      Supplies expense


      51,811


      4.1%


      50,336


      4.0%


      153,827


      4.0%


      148,660


      3.9%

      Depreciation and amortization


      43,985


      3.4%


      41,595


      3.3%


      130,258


      3.4%


      123,089


      3.2%

      Lease and rental expense


      10,067


      0.8%


      10,910


      0.9%


      31,854


      0.8%


      32,248


      0.8%

      Subtotal-operating expenses


      1,019,364


      79.8%


      1,025,734


      81.3%


      3,035,220


      79.8%


      3,045,578


      80.0%

      Income from operations


      257,611


      20.2%


      236,040


      18.7%


      766,386


      20.2%


      762,220


      20.0%

      Interest expense, net


      354


      0.0%


      359


      0.0%


      1,079


      0.0%


      1,103


      0.0%

      Other (income) expense, net


      526


      0.0%


      1,058


      0.1%


      2,337


      0.1%


      1,842


      0.0%

      Income before income taxes


      $256,731


      20.1%


      $234,623


      18.6%


      $762,970


      20.1%


      $759,275


      19.9%




















































      All Behavioral Health Care Services




































      Three months ended


      Three months ended


      Nine months ended


      Nine months ended



      September 30, 2020


      September 30, 2019


      September 30, 2020


      September 30, 2019



      Amount


      % of Net
      Revenues


      Amount


      % of Net
      Revenues 


      Amount


      % of Net
      Revenues


      Amount


      % of Net
      Revenues 

      Net revenues (a)


      $1,299,591


      100.0%


      $1,291,816


      100.0%


      $3,864,823


      100.0%


      $3,898,440


      100.0%

      Operating charges:

















      Salaries, wages and benefits


      684,575


      52.7%


      690,084


      53.4%


      2,027,223


      52.5%


      2,049,731


      52.6%

      Other operating expenses


      253,779


      19.5%


      363,328


      28.1%


      765,006


      19.8%


      891,250


      22.9%

      Supplies expense


      51,858


      4.0%


      50,692


      3.9%


      153,861


      4.0%


      149,809


      3.8%

      Depreciation and amortization


      45,154


      3.5%


      42,436


      3.3%


      134,081


      3.5%


      127,327


      3.3%

      Lease and rental expense


      10,734


      0.8%


      11,822


      0.9%


      34,151


      0.9%


      35,185


      0.9%

      Subtotal-operating expenses


      1,046,100


      80.5%


      1,158,362


      89.7%


      3,114,322


      80.6%


      3,253,302


      83.5%

      Income from operations


      253,491


      19.5%


      133,454


      10.3%


      750,501


      19.4%


      645,138


      16.5%

      Interest expense, net


      433


      0.0%


      359


      0.0%


      1,184


      0.0%


      1,103


      0.0%

      Other (income) expense, net


      526


      0.0%


      (4,924)


      (0.4)%


      2,337


      0.1%


      (4,138)


      (0.1)%

      Income before income taxes


      $252,532


      19.4%


      $138,019


      10.7%


      $746,980


      19.3%


      $648,173


      16.6%


















      (a) Includes the reversal of CARES Act and other grant income of $9 million and CARES Act and other grant income of $52 million recorded in the three and nine-months periods ended September 30, 2020, respectively.

      We believe that providing our results on a "Same Facility" basis (which is a non-GAAP measure), which includes the operating results for facilities and businesses operated in both the current year and prior year periods, is helpful to our investors as a measure of our operating performance. Our Same Facility results also neutralize (if applicable), the effect of material items that are nonrecurring or non-operational in nature including items such as, but not limited to, reserves for various matters, settlements, legal judgments, lawsuits and reserves established in connection with the government's investigation of our behavioral health care facilities, cost related to extinguishment of debt, gains/losses on sales of assets and businesses, impairments of long-lived and intangible assets and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. Our Same Facility basis results exclude from net revenues and other operating expenses, provider tax assessments incurred in each period. However, these provider tax assessments are included in net revenues and other operating expenses as reflected in the table under All Behavioral Health Care Services. The provider tax assessments had no impact on the income before income taxes as reflected on the above tables since the amounts offset between net revenues and other operating expenses. To obtain a complete understanding of our financial performance, the Same Facility results should be examined in connection with our net income as determined in accordance with GAAP and as presented herein and in the condensed consolidated financial statements and notes thereto as contained in our Form 10-K for the year ended December 31, 2019 and Form 10-Q for the quarter ended June 30, 2020.


















      The All Behavioral Health Care Services table summarizes the results of operations for all our behavioral health care facilities during the periods presented. These amounts include: (i) our behavioral health results on a same facility basis, as indicated above; (ii) the impact of provider tax assessments which increased net revenues and other operating expenses but had no impact on income before income taxes, and; (iii) certain other amounts including the results of facilities acquired or opened during the last twelve months as well as the results of certain facilities that were closed or restructured during the past year.

      Universal Health Services, Inc.






      Selected Hospital Statistics






      For the Three Months ended






      September 30, 2020 and 2019
































      AS REPORTED:









































      ACUTE


      BEHAVIORAL HEALTH



      09/30/20


      09/30/19


      %  change


      09/30/20


      09/30/19


      %  change














      Hospitals owned and leased


      26


      26


      0.0%


      330


      327


      0.9%

      Average licensed beds


      6,451


      6,387


      1.0%


      23,566


      23,637


      -0.3%

      Average available beds


      6,279


      6,211


      1.1%


      23,464


      23,536


      -0.3%

      Patient days


      383,958


      356,914


      7.6%


      1,563,259


      1,623,465


      -3.7%

      Average daily census


      4,173.5


      3,879.5


      7.6%


      16,991.9


      17,646.4


      -3.7%

      Occupancy-licensed beds


      64.7%


      60.7%


      6.5%


      72.1%


      74.7%


      -3.4%

      Occupancy-available beds


      66.5%


      62.5%


      6.4%


      72.4%


      75.0%


      -3.4%

      Admissions


      71,682


      79,285


      -9.6%


      115,569


      122,709


      -5.8%

      Length of stay


      5.4


      4.5


      19.0%


      13.5


      13.2


      2.2%














      Inpatient revenue


      $8,137,264


      $7,004,832


      16.2%


      $2,487,568


      $2,536,504


      -1.9%

      Outpatient revenue


      4,128,549


      4,477,277


      -7.8%


      243,600


      257,690


      -5.5%

      Total patient revenue


      12,265,813


      11,482,109


      6.8%


      2,731,168


      2,794,194


      -2.3%

      Other revenue


      127,396


      114,026


      11.7%


      53,105


      57,602


      -7.8%

      Gross hospital revenue


      12,393,209


      11,596,135


      6.9%


      2,784,273


      2,851,796


      -2.4%

      Total deductions


      10,783,206


      10,067,600


      7.1%


      1,484,682


      1,559,980


      -4.8%

      Net hospital revenue 


      $1,610,003


      $1,528,535


      5.3%


      $1,299,591


      $1,291,816


      0.6%



























      SAME FACILITY:




























      ACUTE


      BEHAVIORAL HEALTH



      09/30/20


      09/30/19


      %  change


      09/30/20


      09/30/19


      %  change














      Hospitals owned and leased


      26


      26


      0.0%


      312


      312


      0.0%

      Average licensed beds


      6,451


      6,387


      1.0%


      23,440


      23,350


      0.4%

      Average available beds


      6,279


      6,211


      1.1%


      23,338


      23,249


      0.4%

      Patient days


      383,958


      356,914


      7.6%


      1,556,152


      1,609,071


      -3.3%

      Average daily census


      4,173.5


      3,879.5


      7.6%


      16,914.7


      17,489.9


      -3.3%

      Occupancy-licensed beds


      64.7%


      60.7%


      6.6%


      72.2%


      74.9%


      -3.7%

      Occupancy-available beds


      66.5%


      62.5%


      6.3%


      72.5%


      75.2%


      -3.7%

      Admissions


      71,682


      79,285


      -9.6%


      114,902


      121,345


      -5.3%

      Length of stay


      5.4


      4.5


      19.0%


      13.5


      13.3


      2.1%

      Universal Health Services, Inc.






      Selected Hospital Statistics






      For the Nine Months ended






      September 30, 2020 and 2019
































      AS REPORTED:









































      ACUTE


      BEHAVIORAL HEALTH



      09/30/20


      09/30/19


      %  change


      09/30/20


      09/30/19


      %  change














      Hospitals owned and leased


      26


      26


      0.0%


      330


      327


      0.9%

      Average licensed beds


      6,451


      6,376


      1.2%


      23,591


      23,792


      -0.8%

      Average available beds


      6,279


      6,200


      1.3%


      23,488


      23,692


      -0.9%

      Patient days


      1,071,830


      1,084,534


      -1.2%


      4,620,471


      4,874,801


      -5.2%

      Average daily census


      3,911.8


      3,972.6


      -1.5%


      16,863.0


      17,856.4


      -5.6%

      Occupancy-licensed beds


      60.6%


      62.3%


      -2.7%


      71.5%


      75.1%


      -4.8%

      Occupancy-available beds


      62.3%


      64.1%


      -2.8%


      71.8%


      75.4%


      -4.7%

      Admissions


      213,658


      238,827


      -10.5%


      339,356


      368,103


      -7.8%

      Length of stay


      5.0


      4.5


      10.5%


      13.6


      13.2


      2.8%














      Inpatient revenue


      $22,695,513


      $21,220,471


      7.0%


      $7,298,466


      $7,568,129


      -3.6%

      Outpatient revenue


      12,204,970


      13,137,199


      -7.1%


      719,513


      792,929


      -9.3%

      Total patient revenue


      34,900,483


      34,357,670


      1.6%


      8,017,979


      8,361,058


      -4.1%

      Other revenue


      513,423


      337,369


      52.2%


      223,212


      168,341


      32.6%

      Gross hospital revenue


      35,413,906


      34,695,039


      2.1%


      8,241,191


      8,529,399


      -3.4%

      Total deductions


      30,815,348


      30,119,951


      2.3%


      4,376,368


      4,630,959


      -5.5%

      Net hospital revenue 


      $4,598,558


      $4,575,088


      0.5%


      $3,864,823


      $3,898,440


      -0.9%



























      SAME FACILITY:




























      ACUTE


      BEHAVIORAL HEALTH



      09/30/20


      09/30/19


      %  change


      09/30/20


      09/30/19


      %  change














      Hospitals owned and leased


      26


      26


      0.0%


      312


      312


      0.0%

      Average licensed beds


      6,451


      6,376


      1.2%


      23,441


      23,333


      0.5%

      Average available beds


      6,279


      6,200


      1.3%


      23,339


      23,233


      0.5%

      Patient days


      1,071,830


      1,084,534


      -1.2%


      4,598,843


      4,823,337


      -4.7%

      Average daily census


      3,911.8


      3,972.6


      -1.5%


      16,784.1


      17,667.9


      -5.0%

      Occupancy-licensed beds


      60.6%


      62.3%


      -2.7%


      71.6%


      75.7%


      -5.4%

      Occupancy-available beds


      62.3%


      64.1%


      -2.8%


      71.9%


      76.0%


      -5.4%

      Admissions


      213,658


      238,827


      -10.5%


      337,566


      363,608


      -7.2%

      Length of stay


      5.0


      4.5


      10.5%


      13.6


      13.3


      2.7%

      SOURCE Universal Health Services, Inc.

      Modal title

      Also from this source

      UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT SEPTEMBER HEALTHCARE CONFERENCES

      UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT SEPTEMBER HEALTHCARE CONFERENCES

      Universal Health Services, Inc. (NYSE: UHS) is scheduled to present at the following conferences: September 8, 2026, at 8:45am ET at the Wells Fargo...

      Universal Health Services, Inc. Completes Acquisition of Talkspace, Inc.

      Universal Health Services, Inc. Completes Acquisition of Talkspace, Inc.

      Universal Health Services, Inc. (NYSE: UHS) today announced the successful completion of its acquisition of Talkspace, Inc. (NASDAQ: TALK), bringing...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Conference Call Announcements

      Conference Call Announcements

      Earnings

      Earnings

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.